Key takeaway
Spain’s draft Royal Decree would update national biocides registration and operational requirements, clarify competent authority roles and support alignment with the EU Biocidal Products Regulation and ECHA processes.
The draft sets out national rules complementing the EU Biocidal Products Regulation, including conditions for authorisation, manufacture, packaging, storage, commercialisation and use of biocides in Spain. It also addresses the national Official Register of Biocides, the Register of Establishments and Biocidal Services (ROESB), training requirements for biocide treatments, and an updated approach to infringements and sanctions.
Companies should expect closer alignment to EU submission workflows, including use of ECHA’s R4BP platform for communications, and clearer expectations on registration and market oversight. Operationally, the draft includes detailed requirements for storage and sale, such as separation from food and feed, controlled access for certain products, and traceability expectations, all of which can affect distributors, service providers and industrial users.
Source basis: Draft Spanish Royal Decree regulating biocides registration and conditions, published via TRIS notification 27630
Spain has published a draft Royal Decree intended to modernise its national framework for biocides, updating how products are registered, how establishments and service providers are overseen, and how staff competency requirements are managed in practice.
The draft is framed as a complementary national layer to the EU Biocidal Products Regulation (Regulation (EU) No 528/2012). While the EU regulation applies directly, Spain’s draft explains that legacy national rules remain relevant for questions such as the division of responsibilities between state and regional authorities, national registers and certain operational controls.
The proposal sets out conditions for authorisation, manufacture, packaging, storage, commercialisation and use of biocides in Spain. It also provides for a national, public Official Register of Biocides in which authorised products are to be recorded, and it ties registration obligations to whether active substances are on the EU list of approved substances for the relevant product type or remain in the EU review programme.
Communications relating to registration are described as being handled through the ECHA “Register for Biocidal Products” (R4BP) platform for the relevant biocides, reflecting the operational reality that many regulatory exchanges for biocides are routed via EU-level tools.
The draft allocates roles across multiple bodies. It describes responsibilities for the Ministry of Health, including authorisation and register management, while recognising input from other ministries and national bodies for areas such as environmental protection and animal health. It also sets out enforcement expectations for Spain’s autonomous communities and the cities of Ceuta and Melilla, including market surveillance and sanctioning powers within their territories.
On the operational side, the draft includes detailed conditions for manufacturing and storage. It describes expectations for secure and suitable storage areas, separation from food and feed, and access controls. It also prohibits storing biocides in homes and other inappropriate locations, reflecting a focus on preventing misuse and reducing exposure risks.
If adopted, Spain’s draft Royal Decree would refresh the national rules that sit alongside EU biocides requirements, bringing greater clarity to registration workflows, oversight responsibilities and practical storage and commercialisation conditions. Manufacturers, distributors and biocidal service providers operating in Spain should review how their current procedures map to the draft’s register, traceability and competency expectations.
The UK-EU SPS Agreement will align UK sanitary and phytosanitary rules with EU legislation, affecting food safety, pesticides, biocides and agricultural regulation.
ECHA has supported ethanol approval for key disinfectant product types, with the final decision now moving to the European Commission and Member States.
IPBC alternatives face regulatory and technical hurdles under EU BPR. Learn why Fludioxonil and Pythium oligandrum fall short and why IPBC remains vital.
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
